In 4T1 tumor-bearing mice, increased expression of PD-1/PD-L1 axis components on B cells and MDSCs25 suggests the possible engagement of this pathway between MDSCs and B cells, inducing immune effects during tumor progression. The gene discussed is CD274; the disease is neoplasm.